FDA rejects CV outcomes claim for Merck diabetes drugs

10th April 2017 Uncategorised 0

The US Food and Drug Administration has dealt Merck & Co a blow in turning down its request to have cardiovascular outcomes data added to the labels of its diabetes drugs Januvia and Janumet.

More: FDA rejects CV outcomes claim for Merck diabetes drugs
Source: News